Fecal Fat - Triglycerides Test · Stool

If you are losing weight for no reason, seeing oily or floating stools, or struggling with persistent diarrhea and bloating, your pancreas may be failing to digest the fat you eat. This test looks directly at that process by measuring fat that escapes digestion and ends up in your stool.

Healthy adults excrete only about 2 to 5 grams of fat per day regardless of what they eat. When that number climbs, it signals a breakdown somewhere in the chain: pancreatic enzymes, bile, or the intestinal lining. The pattern of fat left behind helps point to where the problem is.

What This Test Actually Measures

Fecal fat, triglycerides (the storage form of dietary fat) is one of several fat fractions a stool lipid profile can break out. Dietary fat arrives in the intestine mostly as triglycerides. Gastric and pancreatic lipases (enzymes that cut fat molecules apart) normally slice triglycerides into smaller pieces called monoglycerides and free fatty acids, which the intestinal lining can absorb.

When lipase activity is insufficient, intact triglycerides slip past the small intestine and into the colon. When absorption at the gut wall fails, fatty acids and monoglycerides pile up even when digestion worked. The ratio tells a story about whether the problem is digestion, absorption, or both.

Reading the Pattern

A lipidomic study in children with cystic fibrosis found that fecal triglycerides served as the main marker of fat maldigestion (insufficient lipase or pancreatic output), while fecal monoglycerides and fatty acids reflected malabsorption at the intestinal lining. Clusters of high triglycerides, monoglycerides, and fatty acids together were linked to worse nutritional status and shifts in gut bacteria toward less Bacteroidota and Verrucomicrobiota and more Proteobacteria.

Source: Asensio-Grau et al. 2024, Pediatric Research (children with cystic fibrosis).

Why the Triglyceride Number Alone Can Mislead You

This is where fecal triglycerides become tricky. In adults with chronic pancreatic insufficiency studied in the 1980s, fecal triglyceride content was not actually higher than in controls, even though fatty acid content was. The reason: colon bacteria break down any undigested triglycerides that reach the large intestine, converting them to fatty acids before they exit the body. So severe pancreatic failure can sometimes produce a normal-looking triglyceride reading and a markedly elevated fatty acid reading.

This is not a paradox. It is a reminder that fecal triglycerides are most useful when read alongside total fecal fat, fatty acids, and a pancreatic enzyme test like fecal elastase. On their own, they can underestimate severe pancreatic disease. Together with the full lipid profile, they help localize where digestion is actually breaking down.

Pancreatic Exocrine Insufficiency

Exocrine pancreatic insufficiency (EPI) is the most common reason adults end up with elevated fecal fat. It develops when the pancreas cannot make or deliver enough digestive enzymes, most often from chronic pancreatitis driven by alcohol, smoking, or genetic mutations. In 870 chronic pancreatitis patients studied retrospectively, 59% of those with ongoing heavy drinking had exocrine insufficiency compared to 29% of former drinkers.

Pancreatic insufficiency is not benign. In a prospective study of 430 chronic pancreatitis patients, those with EPI had significantly higher mortality, independent of other risk factors. A separate analysis of the same cohort found EPI linked to a higher rate of cardiovascular events alongside smoking and hypertension. Catching the malabsorption early matters, because untreated EPI drives nutrient deficiencies, bone loss, and accelerated decline.

Cystic Fibrosis

Most people with cystic fibrosis develop pancreatic insufficiency, and fecal fat measurement remains central to tracking how well enzyme replacement is working. Fecal lipid profiling in CF children groups people into clusters that correlate with nutritional status and gut microbiota composition. In a randomized trial of 66 CF children, a structured lipid supplement improved fat absorption, weight gain, and fatty acid status.

Intrahepatic Cholestasis of Pregnancy

A less widely recognized cause of steatorrhea is intrahepatic cholestasis of pregnancy, where bile flow slows and fat cannot be properly solubilized for absorption. In a study of 23 affected patients, many had significant steatorrhea, with fecal fat reaching up to about 31 grams per day. Severity correlated with cholestasis severity, maternal weight loss, and higher rates of premature delivery and fetal distress.

Severe Malnutrition and Growth Failure

In severe childhood malnutrition, over half of children have impaired handling of dietary lipids, with problems spanning solubilization, hydrolysis, and absorption. Labeled triglyceride tracing shows fat losses often exceeding 20% of the ingested dose, improving with nutritional rehabilitation. For adults, persistent unexplained weight loss combined with oily stools is a reason to measure fecal fat rather than assume a dietary cause.

When Results Can Be Misleading

A stool fat result is only as reliable as the collection behind it. A few specific factors can make your reading hard to interpret:

• Dietary fat intake before collection: research in chronic pancreatitis patients and healthy controls showed that standardized fat intake before stool collection is essential to measure malabsorption accurately. Very low-fat intake during the collection window can produce a falsely reassuring result.
• Orlistat and similar lipase blockers: orlistat raises fecal fat about 6 to 9 times above baseline by design. If you are taking this medication, your stool fat result reflects the drug, not underlying pancreatic disease.
• Ezetimibe: this cholesterol absorption blocker increases fecal cholesterol specifically. In a randomized trial, ezetimibe reduced serum cholesterol while leaving gut microbiota largely unchanged, indicating the fecal effect comes from blocked absorption rather than gut disease.
• Active diarrhea from other causes: diarrhea itself can mildly raise fecal fat excretion up to about 14 grams per day without a primary defect in fat digestion or absorption, making moderate elevations less specific in that context.

Tracking Your Trend

A single stool fat value is a snapshot that depends heavily on what you ate in the days before collection, how complete the collection was, and whether you were on interfering medications. Serial tracking matters more than any single reading. If you have symptoms pointing to malabsorption, a baseline measurement establishes where you start. A retest in 3 to 6 months after starting pancreatic enzyme replacement, a diet change, or an MCT (medium-chain triglyceride) supplement shows whether the intervention is actually moving the biology. Annual monitoring makes sense for anyone with chronic pancreatitis, cystic fibrosis, or past pancreatic surgery.

What to Do With an Abnormal Result

Elevated fecal fat is a starting point, not an endpoint. The next step is figuring out where digestion is breaking down. Fecal elastase-1 measures pancreatic enzyme output directly and is the most common next test. A meta-analysis found it to be a sensitive tool for exocrine pancreatic insufficiency in high-risk populations, though moderately specific. The 13C-mixed triglyceride breath test offers another functional measure.

If pancreatic insufficiency is confirmed, a gastroenterologist can prescribe pancreatic enzyme replacement therapy and investigate underlying causes like chronic pancreatitis, pancreatic cancer, or cystic fibrosis. If pancreatic function looks normal but fat is still elevated, the workup shifts to intestinal causes: celiac disease, inflammatory bowel disease, bile acid problems, or post-surgical anatomy. Imaging of the pancreas (CT or MRI) is often part of this workup. This is not a result to sit on. Undiagnosed malabsorption quietly drains nutrients, bone mineral density, and muscle mass over time.